Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine
Open Access
- 22 April 2019
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (8), 1986
- https://doi.org/10.3390/ijms20081986
Abstract
Immune responses to human cytomegalovirus (CMV) can be used to assess immune fitness in an individual. Further to its clinical significance in posttransplantation settings, emerging clinical and translational studies provide examples of immune correlates of protection pertaining to anti-CMV immune responses in the context of cancer or infectious diseases, e.g., tuberculosis. In this viewpoint, we provide a brief overview about CMV-directed immune reactivity and immune fitness in a clinical context and incorporate some of our own findings obtained from peripheral blood or tumour-infiltrating lymphocytes (TIL) from patients with advanced cancer. Observations in patients with solid cancers whose lesions contain both CMV and tumour antigen-specific T-cell subsets are highlighted, due to a possible CMV-associated “bystander” effect in amplifying local inflammation and subsequent tumour rejection. The role of tumour-associated antibodies recognising diverse CMV-derived epitopes is also discussed in light of anti-cancer immune responses. We discuss here the use of anti-CMV immune responses as a theranostic tool—combining immunodiagnostics with a personalised therapeutic potential—to improve treatment outcomes in oncological indications.Keywords
Funding Information
- Champalimaud Foundation (n.a.)
This publication has 66 references indexed in Scilit:
- Survival in Patients with Glioblastoma Receiving ValganciclovirNew England Journal of Medicine, 2013
- CD39 and CD73 in immunity and inflammationTrends in Molecular Medicine, 2013
- γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemiaLeukemia, 2013
- Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus‐specific T‐cells in patients with glioblastoma multiformeImmunology & Cell Biology, 2012
- T Cell Receptor αβ Diversity Inversely Correlates with Pathogen-Specific Antibody Levels in Human Cytomegalovirus InfectionScience Translational Medicine, 2012
- The immune response to human CMVFuture Virology, 2012
- Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificityEuropean Journal of Immunology, 2010
- Severe Cytomegalovirus-Associated Esophagitis in an Immunocompetent Patient after Short-Term Steroid TherapyJournal of Clinical Microbiology, 2009
- Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and β 1 and β 3 integrinsProceedings of the National Academy of Sciences, 2008
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastomaNeuro-Oncology, 2008